Immunology letters
Enrichment of CD103+ CD4+ T cells in bone metastases compared to non-malignant controls.
Elias Brauneck, Julian Kylies, Anne Marie Assemissen, Moritz Kruppa, Niklas Kruppa, Yagana Wahid, Franziska Brauneck, Walter Fiedler, Lennart Viezens, Jasmin Wellbrock, Leon-Gordian Leonhardt
Published: 202610.1016/j.imlet.2026.107135
Abstract
BACKGROUND: Bone metastasis (BoM) is a frequent complication of solid tumors, leading to poor prognosis and reduced survival. CD103⁺ tumor-infiltrating lymphocytes (TILs) are critical for antitumor immunity, yet studies have largely focused on CD8⁺ s…
Preview only. Read the full abstract at the source